project id: TCGA-LUAD; case submitter id: TCGA-55-8505; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 62; days to birth: -22676; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 22676; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 440.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; oct embedded: No; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 10.0; percent necrosis: 2.0; percent neutrophil infiltration: 10.0; percent normal cells: 18.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 65.0;